% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • emapsoda emapsoda Apr 26, 2013 10:32 AM Flag

    Receives Positive CHMP Opinion

    The company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a conditional approval of Erivedge (vismodegib) for the treatment of adult patients with symptomatic metastatic basal cell carcinoma. Strong technical buy at stoxline website.

2.86+0.02(+0.70%)10:07 AMEDT